![1]()
News
Epinephrine linked with more refractory cardiogenic shock after acute MI
April 18, 2019
Is there a difference in safety and efficacy when using epinephrine versus norepinephrine for cardiogenic shock after successful reperfusion in acute myocardial infarction (AMI)?
![1]()
News
Poor response to statins hikes risk of cardiovascular events
April 17, 2019
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
![1]()
News
Prevalence and outcomes of incidental imaging findings
April 17, 2019
How frequently are incidental findings on imaging identified and how often do these findings represent true pathology?
![1]()
News
More Medicare beneficiaries receiving hospice care services than in previous years
April 16, 2019
For patients with Medicare Fee-for-Service and Medicare Advantage, what are the trends regarding where they die and the type of health care received around the time of death?
![1]()
News
Statin exposure associated with idiopathic inflammatory myositis
April 15, 2019
What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?
![1]()
News
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
April 14, 2019
NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore
![1]()
News
Cost gap widens between brand-name, generic drugs
April 12, 2019
Generics represent almost 90% of prescriptions filled in the United States but less than 25% of spending.
![1]()
News
Nontraditional specialty physicians supplement hospitalist staffing
April 12, 2019
Emergency medicine and critical care physicians had the largest representative increase in HM groups.
News
Proportion of women speaking at medical conferences rises over decade
April 12, 2019
Though the proportion of female speakers at medical conferences has increased during the last decade, women continue to be underrepresented.
![1]()
News
Rivaroxaban versus heparin at preventing recurrent, cancer-related VTE
April 12, 2019
Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous thromboembolism (VTE)?
